新型コロナウイルス感染症ポイントオブケア(POC)検査:医療機器パイプライン分析2020

GlobalDataが発行した調査報告書(GD21MC065)
◆英語タイトル:COVID-19 Point of Care (POC) Tests - Medical Devices Pipeline Assessment, 2020
◆商品コード:GD21MC065
◆発行会社(リサーチ会社):GlobalData
◆発行日:2020年12月1日
◆ページ数:491
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥552,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD8,000 ⇒換算¥1,104,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD12,000 ⇒換算¥1,656,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

❖ レポートの概要 ❖

COVID-19 Point of Care (POC) Tests – Medical Devices Pipeline Assessment, 2020
Summary

GlobalData’s Medical Devices sector report, “COVID 19 point of care (POC) Tests – Medical Devices Pipeline Assessment, 2020″ provides comprehensive information about the COVID 19 point of care (POC) Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

COVID 19 Point of Care (POC) Tests are used to detect the presence or activity of COVID-19 antigen. This segment includes rapid tests and point of care tests for COVID-19.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the COVID 19 point of care (POC) Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of COVID 19 point of care (POC) Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to Buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of COVID 19 point of care (POC) Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

❖ レポートの目次 ❖

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 COVID 19 point of care (POC) Tests Overview
3 Products under Development
3.1 COVID 19 point of care (POC) Tests – Pipeline Products by Stage of Development
3.2 COVID 19 point of care (POC) Tests – Pipeline Products by Territory
3.3 COVID 19 point of care (POC) Tests – Pipeline Products by Regulatory Path
3.4 COVID 19 point of care (POC) Tests – Pipeline Products by Estimated Approval Date
3.5 COVID 19 point of care (POC) Tests – Ongoing Clinical Trials
4 COVID 19 point of care (POC) Tests – Pipeline Products under Development by Companies
4.1 COVID 19 point of care (POC) Tests Companies – Pipeline Products by Stage of Development
4.2 COVID 19 point of care (POC) Tests – Pipeline Products by Stage of Development
5 COVID 19 point of care (POC) Tests Companies and Product Overview
5 COVID 19 point of care Companies and Product Overview
6 COVID 19 point of care – Recent Developments
7 Appendix

List of Tables
Table 1: COVID 19 point of care (POC) Tests - Pipeline Products by Stage of Development
Table 2: COVID 19 point of care (POC) Tests - Pipeline Products by Territory
Table 3: COVID 19 point of care (POC) Tests - Pipeline Products by Regulatory Path
Table 4: COVID 19 point of care (POC) Tests - Pipeline Products by Estimated Approval Date
Table 5: COVID 19 point of care (POC) Tests - Ongoing Clinical Trials
Table 6: COVID 19 point of care (POC) Tests Companies - Pipeline Products by Stage of Development
Table 7: COVID 19 point of care (POC) Tests - Pipeline Products by Stage of Development
Table 8: 20/20 GeneSystems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: CoronaCheck COVID-19 Rapid Antibody Test Kit - OTC - Product Status
Table 10: CoronaCheck COVID-19 Rapid Antibody Test Kit - OTC - Product Description
Table 11: 3a-Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Microbial-Enzyme Screening Test - COVID-19 - Product Status
Table 13: Microbial-Enzyme Screening Test - COVID-19 - Product Description
Table 14: RT-PCR COVID-19 Test Kit - Product Status
Table 15: RT-PCR COVID-19 Test Kit - Product Description
Table 16: 3M Co Pipeline Products & Ongoing Clinical Trials Overview
Table 17: Rapid COVID-19 Test - Product Status
Table 18: Rapid COVID-19 Test - Product Description
Table 19: Abbott Laboratories Pipeline Products & Ongoing Clinical Trials Overview
Table 20: Panbio COVID-19 IgG/IgM Rapid Test Device - Product Status
Table 21: Panbio COVID-19 IgG/IgM Rapid Test Device - Product Description
Table 22: Abingdon Health Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 23: AbC-19 Rapid Test - Product Status
Table 24: AbC-19 Rapid Test - Product Description
Table 25: QwikZyme - Product Status
Table 26: QwikZyme - Product Description
Table 27: Abnova Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 28: COVID-19 Human IgM/IgG Rapid Test - Product Status
Table 29: COVID-19 Human IgM/IgG Rapid Test - Product Description
Table 30: Lateral Flow Rapid Test - COVID-19 - Product Status
Table 31: Lateral Flow Rapid Test - COVID-19 - Product Description
Table 32: Serum Antibody Rapid Test - COVID-19 - Product Status
Table 33: Serum Antibody Rapid Test - COVID-19 - Product Description
Table 34: Abnova Corp - Ongoing Clinical Trials Overview
Table 35: Serum Antibody Rapid Test - COVID-19 - Study Evaluate the Efficacy of Serum Antibody Rapid Test - COVID-19
Table 36: Absea Biotechnology Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 37: MEGA Test - SARS-CoV-2 - Product Status
Table 38: MEGA Test - SARS-CoV-2 - Product Description
Table 39: Absology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 40: Absoludy COVID-19 IgM/IgG Rapid Test - Product Status
Table 41: Absoludy COVID-19 IgM/IgG Rapid Test - Product Description
Table 42: Academia Sinica Pipeline Products & Ongoing Clinical Trials Overview
Table 43: Anti-SARS-CoV-2 Nucleocapsid Protein Human IgM/IgG Rapid Detection Kit - Product Status
Table 44: Anti-SARS-CoV-2 Nucleocapsid Protein Human IgM/IgG Rapid Detection Kit - Product Description
Table 45: SARS-CoV-2 Nucleocapsid Protein Rapid Detection Kit - Product Status
Table 46: SARS-CoV-2 Nucleocapsid Protein Rapid Detection Kit - Product Description
Table 47: Accel Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 48: Rapid C2T Total Antibodies (IgG/IgM) Card - Product Status
Table 49: Rapid C2T Total Antibodies (IgG/IgM) Card - Product Description
Table 50: Accobiotech Sdn Bhd Pipeline Products & Ongoing Clinical Trials Overview

List of Figures
Figure 1: COVID 19 point of care (POC) Tests - Pipeline Products by Stage of Development
Figure 2: COVID 19 point of care (POC) Tests - Pipeline Products by Territory
Figure 3: COVID 19 point of care (POC) Tests - Pipeline Products by Regulatory Path
Figure 4: COVID 19 point of care (POC) Tests - Pipeline Products by Estimated Approval Date
Figure 5: COVID 19 point of care (POC) Tests - Ongoing Clinical Trials

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 新型コロナウイルス感染症ポイントオブケア(POC)検査:医療機器パイプライン分析2020(COVID-19 Point of Care (POC) Tests - Medical Devices Pipeline Assessment, 2020)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆